发布求助
文献互助 智能选刊 最新文献

European cardiology最新文献

筛选
英文 中文
Coronary Artery Spasm: A Special Focus Issue 冠状动脉痉挛:一个特别的焦点问题
European cardiology Pub Date : 2023-09-01 DOI: 10.15420/ecr.2023.11
Juan Carlos Kaski, Hiroaki Shimokawa
{"title":"Coronary Artery Spasm: A Special Focus Issue","authors":"Juan Carlos Kaski, Hiroaki Shimokawa","doi":"10.15420/ecr.2023.11","DOIUrl":"https://doi.org/10.15420/ecr.2023.11","url":null,"abstract":"","PeriodicalId":93994,"journal":{"name":"European cardiology","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135048756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Asian Pacific Society of Cardiology Consensus Statements on the Diagnosis and Management of Obstructive Sleep Apnoea in Patients with Cardiovascular Disease. 亚太心脏病学会关于心血管疾病患者阻塞性睡眠呼吸暂停的诊断和管理的共识声明。
IF 3
European cardiology Pub Date : 2022-06-20 eCollection Date: 2022-02-01 DOI: 10.15420/ecr.2021.59
Jack Wei Chieh Tan, Leong Chai Leow, Serene Wong, See Meng Khoo, Takatoshi Kasai, Pipin Kojodjojo, Duong-Quy Sy, Chuen Peng Lee, Naricha Chirakalwasan, Hsueh-Yu Li, Natalie Koh, Adeline Tan, Thun How Ong, Aye Thandar Aung, Song Tar Toh, Chi-Hang Lee
{"title":"Asian Pacific Society of Cardiology Consensus Statements on the Diagnosis and Management of Obstructive Sleep Apnoea in Patients with Cardiovascular Disease.","authors":"Jack Wei Chieh Tan,&nbsp;Leong Chai Leow,&nbsp;Serene Wong,&nbsp;See Meng Khoo,&nbsp;Takatoshi Kasai,&nbsp;Pipin Kojodjojo,&nbsp;Duong-Quy Sy,&nbsp;Chuen Peng Lee,&nbsp;Naricha Chirakalwasan,&nbsp;Hsueh-Yu Li,&nbsp;Natalie Koh,&nbsp;Adeline Tan,&nbsp;Thun How Ong,&nbsp;Aye Thandar Aung,&nbsp;Song Tar Toh,&nbsp;Chi-Hang Lee","doi":"10.15420/ecr.2021.59","DOIUrl":"https://doi.org/10.15420/ecr.2021.59","url":null,"abstract":"<p><p>Obstructive sleep apnoea (OSA) is strongly associated with cardiovascular disease (CVD). However, evidence supporting this association in the Asian population is scarce. Given the differences in the epidemiology of CVD and cardiovascular risk factors, as well as differences in the availability of healthcare resources between Asian and Western countries, an Asian Pacific Society of Cardiology (APSC) working group developed consensus recommendations on the management of OSA in patients with CVD in the Asia-Pacific region. The APSC expert panel reviewed and appraised the available evidence using the Grading of Recommendations Assessment, Development, and Evaluation system. Consensus recommendations were developed and put to an online vote. Consensus was reached when 80% of votes for a given recommendation were in support of 'agree' or 'neutral.' The resulting statements provide guidance on the assessment and treatment of OSA in patients with CVD in the Asia-Pacific region. The APSC hopes for these recommendations to pave the way for screening, early diagnosis and treatment of OSA in the Asia-Pacific region.</p>","PeriodicalId":93994,"journal":{"name":"European cardiology","volume":" ","pages":"e16"},"PeriodicalIF":3.0,"publicationDate":"2022-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/da/92/ecr-17-e16.PMC9247989.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40487808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Ethnic and Regional Differences in the Management of Angina: The Way Forward. 心绞痛管理的民族和地区差异:前进的道路。
IF 3
European cardiology Pub Date : 2022-03-07 eCollection Date: 2022-02-01 DOI: 10.15420/ecr.2021.60
Jack C Barton, Juan Carlos Kaski
{"title":"Ethnic and Regional Differences in the Management of Angina: The Way Forward.","authors":"Jack C Barton,&nbsp;Juan Carlos Kaski","doi":"10.15420/ecr.2021.60","DOIUrl":"https://doi.org/10.15420/ecr.2021.60","url":null,"abstract":"<p><p>For decades, there has been great interest in ethnic differences in the management of angina and stable cardiovascular disease. Clinical decisionmaking is known to be both consciously and unconsciously influenced by a patient's demographics, and this is due to in part to differences in clinical guidance and opinion. However, the evidence supporting such decision-making is sparse. Nonetheless, there is overwhelming evidence that international, national, regional, institutional, departmental and individual bias disproportionately affect subgroups of the population, resulting in adverse patient outcomes. While without doubt there will be rapid advancements in individualised therapies over the coming years and decades, the most beneficial immediate action clinicians can take is to reduce disparities in both the evidence base and care provision. Doing so will require great collaborative effort.</p>","PeriodicalId":93994,"journal":{"name":"European cardiology","volume":" ","pages":"e07"},"PeriodicalIF":3.0,"publicationDate":"2022-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5a/9b/ecr-17-e07.PMC8924955.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40316589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circulating MicroRNAs as Novel Biomarkers in Risk Assessment and Prognosis of Coronary Artery Disease. 循环microrna作为冠状动脉疾病风险评估和预后的新生物标志物。
IF 3
European cardiology Pub Date : 2022-03-07 eCollection Date: 2022-02-01 DOI: 10.15420/ecr.2021.47
Chiara Vavassori, Eleonora Cipriani, Gualtiero Ivanoe Colombo
{"title":"Circulating MicroRNAs as Novel Biomarkers in Risk Assessment and Prognosis of Coronary Artery Disease.","authors":"Chiara Vavassori,&nbsp;Eleonora Cipriani,&nbsp;Gualtiero Ivanoe Colombo","doi":"10.15420/ecr.2021.47","DOIUrl":"https://doi.org/10.15420/ecr.2021.47","url":null,"abstract":"<p><p>Coronary artery disease is among the leading causes of death worldwide. Nevertheless, available cardiovascular risk prediction algorithms still miss a significant portion of individuals at-risk. Thus, the search for novel non-invasive biomarkers to refine cardiovascular risk assessment is both an urgent need and an attractive topic, which may lead to a more accurate risk stratification and/or prognostic score definition for coronary artery disease. A new class of such non-invasive biomarkers is represented by extracellular microRNAs (miRNAs) circulating in the blood. MiRNAs are non-coding RNA of 22-25 nucleotides in length that play a significant role in both cardiovascular physiology and pathophysiology. Given their high stability and conservation, resistance to degradative enzymes, and detectability in body fluids, circulating miRNAs are promising emerging biomarkers, and specific expression patterns have already been associated with a wide range of cardiovascular conditions. In this review, an overview of the role of blood miRNAs in risk assessment and prognosis of coronary artery disease is given.</p>","PeriodicalId":93994,"journal":{"name":"European cardiology","volume":" ","pages":"e06"},"PeriodicalIF":3.0,"publicationDate":"2022-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2c/fd/ecr-17-e06.PMC8924954.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40316588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Arrhythmias in Chronic Kidney Disease. 慢性肾病中的心律失常。
IF 3
European cardiology Pub Date : 2022-03-07 eCollection Date: 2022-02-01 DOI: 10.15420/ecr.2021.52
Zaki Akhtar, Lisa Wm Leung, Christos Kontogiannis, Isaac Chung, Khalid Bin Waleed, Mark M Gallagher
{"title":"Arrhythmias in Chronic Kidney Disease.","authors":"Zaki Akhtar,&nbsp;Lisa Wm Leung,&nbsp;Christos Kontogiannis,&nbsp;Isaac Chung,&nbsp;Khalid Bin Waleed,&nbsp;Mark M Gallagher","doi":"10.15420/ecr.2021.52","DOIUrl":"https://doi.org/10.15420/ecr.2021.52","url":null,"abstract":"<p><p>Arrhythmias cause disability and an increased risk of premature death in the general population but far more so in patients with renal failure. The association between the cardiac and renal systems is complex and derives in part from common causality of renal and myocardial injury from conditions including hypertension and diabetes. In many cases, there is a causal relationship, with renal dysfunction promoting arrhythmias and arrhythmias exacerbating renal dysfunction. In this review, the authors expand on the challenges faced by cardiologists in treating common and uncommon arrhythmias in patients with renal failure using pharmacological interventions, ablation and cardiac implantable device therapies. They explore the most important interactions between heart rhythm disorders and renal dysfunction while evaluating the ways in which the coexistence of renal dysfunction and cardiac arrhythmia influences the management of both.</p>","PeriodicalId":93994,"journal":{"name":"European cardiology","volume":" ","pages":"e05"},"PeriodicalIF":3.0,"publicationDate":"2022-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/31/64/ecr-17-e05.PMC8924956.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40316590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Valvular Heart Disease in Patients with Chronic Kidney Disease. 慢性肾病患者的瓣膜性心脏病
IF 3
European cardiology Pub Date : 2022-01-31 eCollection Date: 2022-02-01 DOI: 10.15420/ecr.2021.25
Konstantina Kipourou, Jamie M O'Driscoll, Rajan Sharma
{"title":"Valvular Heart Disease in Patients with Chronic Kidney Disease.","authors":"Konstantina Kipourou,&nbsp;Jamie M O'Driscoll,&nbsp;Rajan Sharma","doi":"10.15420/ecr.2021.25","DOIUrl":"https://doi.org/10.15420/ecr.2021.25","url":null,"abstract":"<p><p>Valvular heart disease (VHD) is highly prevalent in patients with chronic kidney disease (CKD) from the early stages to end-stage renal disease (ESRD). Aortic and mitral valves are the most frequently affected, leading to aortic valve and/or mitral annular calcification, which, in turn, causes either valve stenosis or regurgitation at an accelerated rate compared with the general population. Tricuspid regurgitation is also prevalent in CKD and ESRD, and haemodialysis patients are at an increasingly high risk of infective endocarditis. As for pathophysiology, several mechanisms causing VHD in CKD have been proposed, highlighting the complexity of the process. Echocardiography constitutes the gold standard for the assessment of VHD in CKD/ESRD patients, despite the progress of other imaging modalities. With regard to treatment, the existing 2017 European Society of Cardiology/European Association for Cardio-Thoracic Surgery guidelines on the management of VHD addressing patients with normal kidney function are also applied to patients with CKD/ESRD.</p>","PeriodicalId":93994,"journal":{"name":"European cardiology","volume":" ","pages":"e02"},"PeriodicalIF":3.0,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/57/71/ecr-17-e02.PMC8819604.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39914407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
The 2021 European Heart Failure Guidelines: The Case for Personalised Therapeutics. 2021年欧洲心力衰竭指南:个体化治疗的案例
IF 3
European cardiology Pub Date : 2022-01-28 eCollection Date: 2022-02-01 DOI: 10.15420/ecr.2021.57
Nesan Shanmugam
{"title":"The 2021 European Heart Failure Guidelines: The Case for Personalised Therapeutics.","authors":"Nesan Shanmugam","doi":"10.15420/ecr.2021.57","DOIUrl":"https://doi.org/10.15420/ecr.2021.57","url":null,"abstract":"© RADCLIFFE CARDIOLOGY 2022 www.ECRjournal.com The field of heart failure (HF) has seen the development of unparalleled evidence-based therapies over the last 30 years, with continuous improvement in survival and quality of life for our patients. It is unquestionably an exciting time to be considering or pursuing HF as a subspecialty. Pivotal to and underpinning these advances is the guidance provided by international HF guidelines, particularly from the European Society of Cardiology (ESC). The new 2021 ESC HF guidelines have a total of 41 new and 15 modified recommendations from the 2016 document.1","PeriodicalId":93994,"journal":{"name":"European cardiology","volume":" ","pages":"e01"},"PeriodicalIF":3.0,"publicationDate":"2022-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1c/cb/ecr-17-e01.PMC8819603.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39914406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral Presentation Award Winner: Polysaccharide Peptide of Ganoderma lucidum Reduces Endothelial Injury in Stable Angina and High-risk Patients. 口服报告奖得主:灵芝多糖肽减少稳定型心绞痛和高危患者的内皮损伤。
IF 3
European cardiology Pub Date : 2021-12-14 eCollection Date: 2021-02-01 DOI: 10.15420/ecr.2021.16.PO3
Eliana Susilowati, Djanggan Sargowo, Nadia Ovianti
{"title":"Oral Presentation Award Winner: Polysaccharide Peptide of <i>Ganoderma lucidum</i> Reduces Endothelial Injury in Stable Angina and High-risk Patients.","authors":"Eliana Susilowati,&nbsp;Djanggan Sargowo,&nbsp;Nadia Ovianti","doi":"10.15420/ecr.2021.16.PO3","DOIUrl":"https://doi.org/10.15420/ecr.2021.16.PO3","url":null,"abstract":"","PeriodicalId":93994,"journal":{"name":"European cardiology","volume":" ","pages":"e59"},"PeriodicalIF":3.0,"publicationDate":"2021-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/84/77/ecr-16-e59.PMC8785058.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39879121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Oral Presentation Award Winner: Clinical Efficacy of Intracoronary Papaverine After Nicorandil Administration for Safe and Optimal Fractional Flow Reserve Measurement. 口腔报告奖得主:尼可地尔给药后冠状动脉内罂粟碱用于安全、最佳的血流储备分数测量的临床疗效。
IF 3
European cardiology Pub Date : 2021-12-14 eCollection Date: 2021-02-01 DOI: 10.15420/ecr.2021.16.PO4
Shinjo Sonoda
{"title":"Oral Presentation Award Winner: Clinical Efficacy of Intracoronary Papaverine After Nicorandil Administration for Safe and Optimal Fractional Flow Reserve Measurement.","authors":"Shinjo Sonoda","doi":"10.15420/ecr.2021.16.PO4","DOIUrl":"https://doi.org/10.15420/ecr.2021.16.PO4","url":null,"abstract":"","PeriodicalId":93994,"journal":{"name":"European cardiology","volume":" ","pages":"e60"},"PeriodicalIF":3.0,"publicationDate":"2021-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/72/94/ecr-16-e60.PMC8785100.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39879122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Isocitrate Dehydrogenases in Direct Reprogramming to Cardiomyocytes. 异柠檬酸脱氢酶在心肌细胞直接重编程中的作用。
IF 3
European cardiology Pub Date : 2021-12-14 eCollection Date: 2021-02-01 DOI: 10.15420/ecr.2021.16.PO8
Tomoaki Ishida, Tomoe Ueyama, Ai Baba, Koji Hasegawa, Teruhisa Kawamura
{"title":"The Role of Isocitrate Dehydrogenases in Direct Reprogramming to Cardiomyocytes.","authors":"Tomoaki Ishida,&nbsp;Tomoe Ueyama,&nbsp;Ai Baba,&nbsp;Koji Hasegawa,&nbsp;Teruhisa Kawamura","doi":"10.15420/ecr.2021.16.PO8","DOIUrl":"https://doi.org/10.15420/ecr.2021.16.PO8","url":null,"abstract":"© RADCLIFFE CARDIOLOGY 2021 Access at: www.ECRjournal.com Objectives: Direct reprogramming with introduction of Gata4, Mef2c and Tbx5 (GMT) genes involved in cardiogenesis can convert fibroblasts to induced cardiomyocyte-like cells (iCMs), whereas only a low percentage of iCMs are obtained due to the low proliferative capacity. Recent studies suggest that oestrogen-related receptors (ERRs) are involved in cardiomyocyte maturation during the differentiation from pluripotent stem cells. In addition, ERRγ regulates the density and morphology of mitochondria in matured cardiomyocytes accounting for prominent aerobic metabolism. ERRγ is also known to induce the transcription of isocitrate dehydrogenases (IDHs), one of the tricarboxylic acid cycle regulators. In the present study, we investigate whether ERRγ-IDHmediated mitochondria regulation is involved in cellular metabolism during direct reprogramming to iCMs.","PeriodicalId":93994,"journal":{"name":"European cardiology","volume":" ","pages":"e64"},"PeriodicalIF":3.0,"publicationDate":"2021-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cd/99/ecr-16-e64.PMC8785091.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39879126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信